Achillion Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析

◆英語タイトル:Achillion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4614
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Achillion Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Achillion Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Achillion Pharmaceuticals (Achillion or ‘the company’) is an American biopharmaceutical company that develops, discovers, and markets drugs for the treating infectious diseases such as chronic hepatitis C virus (HCV) and resistant bacterial infections. Its lead drug candidate includes ACH-4471, an inhibitor of factor D that is Phase II clinical trials for patients with paroxysmal nocturnal hemoglobinuria and C3 glomerulopathy. The company is developing ACH-5228, a factor D inhibitor that is in Phase I clinical trial; ACH-5548, a factor D inhibitor; and other factor D inhibitors. It has license agreements with GCA Therapeutics, Ltd and Ora, Inc., as well as a collaboration arrangement with Janssen Pharmaceuticals Inc. The company operates in the US. The company is headquartered in New Haven, Connecticut, the US.

Scope

- Detailed information on Achillion Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Achillion Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Achillion Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Achillion Pharmaceuticals, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Achillion Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Achillion Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Achillion Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Achillion Pharmaceuticals, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Achillion Pharmaceuticals, Inc.: Company Overview
Achillion Pharmaceuticals, Inc.: Overview and Key Facts
Achillion Pharmaceuticals, Inc.: Overview
Achillion Pharmaceuticals, Inc.: Key Facts
Achillion Pharmaceuticals, Inc.: Key Employees
Achillion Pharmaceuticals, Inc.: Key Employee Biographies
Achillion Pharmaceuticals, Inc.: Major Products and Services
Achillion Pharmaceuticals, Inc.: Company History
Achillion Pharmaceuticals, Inc.: Management Statement
Achillion Pharmaceuticals, Inc.: Key Competitors
Achillion Pharmaceuticals, Inc.: Company Analysis
Achillion Pharmaceuticals, Inc.: Business Description
Achillion Pharmaceuticals, Inc.: SWOT Analysis
Achillion Pharmaceuticals, Inc.: SWOT Overview
Achillion Pharmaceuticals, Inc.: Strengths
Achillion Pharmaceuticals, Inc.: Weaknesses
Achillion Pharmaceuticals, Inc.: Opportunities
Achillion Pharmaceuticals, Inc.: Threats
Achillion Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Achillion Pharmaceuticals, Inc.: Financial Deals Overview
Achillion Pharmaceuticals, Inc.: Targets and Partners
Achillion Pharmaceuticals, Inc.: Top Deals 2016 – 2020YTD*
Achillion Pharmaceuticals, Inc.: Advisors
Achillion Pharmaceuticals, Inc.: Top Legal Advisors
Achillion Pharmaceuticals, Inc.: Top Financial Advisors
Achillion Pharmaceuticals, Inc.: Capital Raising
Achillion Pharmaceuticals, Inc.: Private Equity and Ownership
Achillion Pharmaceuticals, Inc.: Recent Developments
Achillion Pharmaceuticals, Inc.: News and Events Summary
Achillion Pharmaceuticals, Inc.: Business Expansion
Achillion Pharmaceuticals, Inc.: Corporate Governance
Achillion Pharmaceuticals, Inc.: Financial Performance
Achillion Pharmaceuticals, Inc.: Market Developments
Achillion Pharmaceuticals, Inc.: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Achillion Pharmaceuticals, Inc.: Key Facts
Table 2: Achillion Pharmaceuticals, Inc.: Key Employees
Table 3: Achillion Pharmaceuticals, Inc.: Company History
Table 4: Achillion Pharmaceuticals, Inc.: Key Competitors
Table 5: Achillion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Achillion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Achillion Pharmaceuticals, Inc.: Targets and Partners
Table 8: Achillion Pharmaceuticals, Inc.: Top Deals 2016 - 2020YTD*
Table 9: Achillion Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Achillion Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Achillion Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 12: Achillion Pharmaceuticals, Inc.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 13: Achillion Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 14: Achillion Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 15: Achillion Pharmaceuticals, Inc.: News and Events Summary
Table 16: Achillion Pharmaceuticals, Inc.: Business Expansion
Table 17: Achillion Pharmaceuticals, Inc.: Corporate Governance
Table 18: Achillion Pharmaceuticals, Inc.: Financial Performance
Table 19: Achillion Pharmaceuticals, Inc.: Market Developments
Table 20: Achillion Pharmaceuticals, Inc.: Research & Development

★海外企業調査レポート[Achillion Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Biofrontera AG (B8F):医療機器:M&Aディール及び事業提携情報
    Summary Biofrontera AG (Biofrontera) is a biopharmaceutical company that develops and commercializes dermatological medications and medical cosmetics. The company’s products comprise Ameluz, BF-RhodoLED and Belixos. Its prescription drug Ameluz is used for the treatment of skin disease actinic kerat …
  • Central Iowa Power Cooperative:企業の戦略的SWOT分析
    Central Iowa Power Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Odakyu Electric Railway:企業の戦略・SWOT・財務分析
    Odakyu Electric Railway - Strategy, SWOT and Corporate Finance Report Summary Odakyu Electric Railway - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • William Hill plc (WMH):企業の財務・戦略的SWOT分析
    William Hill plc (WMH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Grupo Televisa S.A.B.:企業の戦略・SWOT・財務分析
    Grupo Televisa S.A.B. - Strategy, SWOT and Corporate Finance Report Summary Grupo Televisa S.A.B. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Thoresen Thai Agencies Public Company Limited:企業の戦略・SWOT・財務情報
    Thoresen Thai Agencies Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thoresen Thai Agencies Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • International Speedway Corporation:企業の戦略・SWOT・財務分析
    International Speedway Corporation - Strategy, SWOT and Corporate Finance Report Summary International Speedway Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Teva Pharmaceutical Industries Ltd (TEVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Teva Pharmaceutical Industries Ltd (Teva) is a pharmaceutical company that carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines to treat disorders of the central nervous system (CNS), respiratory, cancer, …
  • ChemoCentryx Inc (CCXI):企業の財務・戦略的SWOT分析
    Summary ChemoCentryx Inc (ChemoCentryx) is a biopharmaceutical company that discovers, develops and commercializes orally-administered therapeutics for the treatment of cancer, autoimmune diseases, and inflammatory disorders. The company's lead drug candidate include Avacopan, an orally-administered …
  • Buck Institute for Research on Aging:製薬・医療:M&Aディール及び事業提携情報
    Summary Buck Institute for Research on Aging (Buck Institute) is a biomedical institute that conducts research on aging and chronic disease. The institute concentrates on understanding the connection between aging and chronic disease. It carries out research and develops treatments in the therapeuti …
  • BPH Energy Ltd (BPH):企業の財務・戦略的SWOT分析
    BPH Energy Ltd (BPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • First Republic Bank:企業の戦略・SWOT・財務分析
    First Republic Bank - Strategy, SWOT and Corporate Finance Report Summary First Republic Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ReCor Medical Inc-医療機器分野:企業M&A・提携分析
    Summary ReCor Medical Inc (ReCor Medical) is a medical device company that designs and manufactures a proprietary ultrasound ablation system for performing renal denervation. The company provides technology such as Percutaneous Renal Denervation System (Paradise), a therapeutic non-focused ultrasoun …
  • Nippon Soda Co., Ltd.:企業の戦略・SWOT・財務分析
    Nippon Soda Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Soda Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Korean Air Lines Co Ltd:企業の戦略・SWOT・財務情報
    Korean Air Lines Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Korean Air Lines Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Filinvest Development Corporation (FDC):企業の財務・戦略的SWOT分析
    Filinvest Development Corporation (FDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Nine Entertainment Co. Holdings Ltd:企業の戦略・SWOT・財務分析
    Nine Entertainment Co. Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Nine Entertainment Co. Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Loews Corporation:戦略・SWOT・企業財務分析
    Loews Corporation - Strategy, SWOT and Corporate Finance Report Summary Loews Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Nattopharma ASA (NATTO):企業の財務・戦略的SWOT分析
    Summary Nattopharma ASA (Nattopharma) is a pharmaceutical company that develops and sells vitamin K2 for health care industries. The company's MenaQ7, a vitamin K2 as menaquinone-7 for bone and cardiovascular health and children’s health. Its MenaQ7 varieties are suitable for vegans and vegetarians, …
  • Aero Components Inc.:企業の戦略・SWOT・財務情報
    Aero Components Inc. - Strategy, SWOT and Corporate Finance Report Summary Aero Components Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆